Chronic cough due to nonbronchiectatic suppurative airway disease (bronchiolitis): ACCP evidence-based clinical practice guidelines.

OBJECTIVES To review the role of nonbronchiectatic suppurative airway disease (bronchiolitis) in the spectrum of causes of cough and its management. DESIGN/METHODOLOGY A MEDLINE search (through May 2004) for studies published in the English language since 1980 on human subjects using the medical subject heading terms "cough," "causes of cough," "etiology of cough," "interstitial lung disease," "bronchiolitis," "bronchiolitis obliterans," "diffuse panbronchiolitis," and "inflammatory bowel disease" was performed. Case series and prospective descriptive clinical trials were selected for review. Any references from these studies that were pertinent to the topic were also obtained. RESULTS/CONCLUSIONS In patients with cough in whom other more common causes of cough have been excluded, incomplete or irreversible airflow limitation, small airways disease seen on high-resolution CT scan, or purulent secretions seen on bronchoscopy, should suggest nonbronchiectatic suppurative airways disease (bronchiolitis) as a potential primary cause. Successful management depends on the identification of the specific underlying disorder.

[1]  N. Adams,et al.  Diffuse panbronchiolitis , 2008, European Respiratory Journal.

[2]  C. Picado,et al.  [Pulmonary manifestations of inflammatory bowel disease]. , 2005, Archivos de bronconeumologia.

[3]  E. Gabazza,et al.  In vivo and in vitro effects of macrolide antibiotics on mucus secretion in airway epithelial cells. , 2003, American journal of respiratory and critical care medicine.

[4]  R. Irwin,et al.  Unsuspected bacterial suppurative disease of the airways presenting as chronic cough. , 2003, The American journal of medicine.

[5]  K. Dalhoff,et al.  Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission , 2002, American Journal of Gastroenterology.

[6]  David A. Lynch,et al.  Imaging of Diffuse Lung Disease , 1999 .

[7]  C. Cunningham-Rundles,et al.  Common variable immunodeficiency: clinical and immunological features of 248 patients. , 1999, Clinical immunology.

[8]  S. Han,et al.  Association of HLA class I antigens with diffuse panbronchiolitis in Korean patients. , 1999, American journal of respiratory and critical care medicine.

[9]  S. Kudoh,et al.  Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. , 1998, American journal of respiratory and critical care medicine.

[10]  T. Kohyama,et al.  Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells. , 1997, American journal of respiratory and critical care medicine.

[11]  J. Belaiche,et al.  Increased frequency of bronchial hyperresponsiveness in patients with inflammatory bowel disease , 1995, Allergy.

[12]  T. Colby,et al.  Diffuse panbronchiolitis: diagnosis and distinction from various pulmonary diseases with centrilobular interstitial foam cell accumulations. , 1994, Human pathology.

[13]  C. Liu,et al.  Bronchiolitis following infection in adults and children. , 1993, Clinics in chest medicine.

[14]  H Itoh,et al.  Diffuse panbronchiolitis: correlation of high-resolution CT and pathologic findings. , 1992, Radiology.

[15]  J. Tamaoki,et al.  Effect of indomethacin on bronchorrhea in patients with chronic bronchitis, diffuse panbronchiolitis, or bronchiectasis. , 1992, The American review of respiratory disease.

[16]  S. Swensen,et al.  Bronchiolar disorders. , 2003, American journal of respiratory and critical care medicine.

[17]  T. Colby,et al.  The lung in inflammatory bowel disease. , 2000, The European respiratory journal.

[18]  T. Franquet,et al.  Bronchiolar inflammatory diseases: high-resolution CT findings with histologic correlation , 1999, European Radiology.

[19]  T. Colby,et al.  Bronchiolitis. Pathologic considerations. , 1998, American journal of clinical pathology.

[20]  T. Colby,et al.  Pathologic manifestations of bronchiolitis, constrictive bronchiolitis, cryptogenic organizing pneumonia, and diffuse panbronchiolitis. , 1993, Clinics in chest medicine.

[21]  Eriko Yamaguchi,et al.  Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis. , 1991, Respiration; international review of thoracic diseases.